Salivary progesterone concentrations in symptomatic patients with imminent preterm labor and patients with deliveries beyond 7 days
[Salivary progesterone concentrations in symptomatic patients with imminent preterm labor and patients with deliveries beyond 7 days]Eduardo Reyna-Villasmil1, Jorly Mejía-Montilla2, Nadia Reyna-Villasmil2, Duly Torres-Cepeda1, Martha Rondón-Tapia1, Maira Sarmiento-Piña1, Carlos Briceño-Perez2
1. Servicio de Ginecología y Obstetricia, Hospital Central “Dr. Urquinaona, Maracaibo, Venezuela; 2. Facultad de Medicina de la Universidad del Zulia, Maracaibo, Venezuela.
Downloads
Abstract
Objetivo: Comparar las concentraciones de progesterona en saliva en pacientes sintomáticas con parto pretérmino inminente y pacientes con partos más allá de 7 días. Metodología: Estudio prospectivo y longitudinal realizado en el Hospital Central “Dr. Urquinaona” de Venezuela. Fueron seleccionadas pacientes con parto pretérmino en los siguientes 7 días (grupo A) y con parto pretérmino más allá de los 7 días (grupo B). Se analizaron las características generales, concentraciones de progesterona en saliva, parto pretérmino inminente y eficacia pronóstica. Resultados: Fueron incluidas 327 pacientes, 75 mujeres en el grupo A y 251 pacientes en el grupo B. Las pacientes del grupo A presentaron valores menores de progesterona en saliva (3,003 +/- 447 pg/mL) comparado con las pacientes del grupo B (3,639 +/- 430 pg/mL; p < 0,0001). El valor de corte predictivo fue de 3,100 pg/mL, demostrando un valor área bajo la curva de 0,834 con sensibilidad de 58,7%, especificidad de 84,9%, valor predictivo positivo de 53,7%, valor predictivo negativo de 87,3% y exactitud pronostica de 78,8% para la predicción de parto pretérmino inminente. Conclusiones: Las concentraciones de progesterona en saliva son significativamente más bajas en las pacientes con parto pretérmino inminente, comparado con aquellas pacientes con partos más allá de los 7 días.
Abstract
Objective: To compare progesterone concentrations in saliva in symptomatic patients with imminent preterm labor and patients with deliveries beyond 7 days. Methodology: Prospective and longitudinal study carried out at the Central Hospital "Dr. Urquinaona" of Venezuela. Patients with preterm delivery within 7 days (group A) and with preterm delivery beyond 7 days (group B) were selected. General characteristics, saliva progesterone concentrations, imminent preterm delivery and prognostic efficacy were analyzed. Results: A total of 327 patients were included, 75 women in group A and 251 patients in group B. Patients in group A had lower saliva progesterone values (3.003 +/- 447 pg/mL) compared to patients in group B (3.639 +/- 430 pg/mL; p < 0.0001). The predictive cutoff value was 3,100 pg/mL, demonstrating an area under the curve value of 0.834 with sensitivity of 58.7%, specificity of 84.9%, positive predictive value of 53.7%, negative predictive value of 87.3% and prognostic accuracy of 78.8% for prediction of impending preterm labor. Conclusions: Saliva progesterone concentrations are significantly lower in patients with imminent preterm labor compared to those patients with deliveries beyond 7 days.
References
[1] Hornaday KK, Wood EM, Slater DM. Is there a maternal blood biomarker that can predict spontaneous preterm birth prior to labour onset? A systematic review. PLoS One. 2022;17(4):e0265853.
[2] O'Connell JS, Sakowicz A, Miller ES. Is midtrimester cervical length associated with preterm birth in women evaluated for preterm labor? Am J Perinatol. 2018;35(3):220-224.
[3] Naser AY, Al-Shehri H, Altamimi N, Alrasheed A, Albalawi L. Profile of hospital admissions due to preterm labor and delivery in England. Healthcare (Basel). 2023;11(2):163.
[4] Kolatorova L, Vitku J, Suchopar J, Hill M, Parizek A. Progesterone: A steroid with wide range of effects in physiology as well as human medicine. Int J Mol Sci. 2022;23(14):7989.
[5] Krahel A, Hernik A, Dmitrzak-Weglarz M, Paszynska E. Saliva as diagnostic material and current methods of collection from oral cavity. Clin Lab. 2022;68(10).
[6] Zolotukhin S. Metabolic hormones in saliva: origins and functions. Oral Dis. 2013;19(3):219-229.
[7] Papacosta E, Nassis GP. Saliva as a tool for monitoring steroid, peptide and immune markers in sport and exercise science. J Sci Med Sport. 2011;14(5):424-34.
[8] Maged AM, Mohesen M, Elhalwagy A, Abdelhafiz A. Salivary progesterone and cervical length measurement as predictors of spontaneous preterm birth. J Matern Fetal Neonatal Med. 2015;28(10):1147-51.
[9] Lachelin GC, McGarrigle HH, Seed PT, Briley A, Shennan AH, Poston L. Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery. BJOG. 2009;116(11):1515-9.
[10] Priya B, Mustafa MD, Guleria K, Vaid NB, Banerjee BD, Ahmed RS. Salivary progesterone as a biochemical marker to predict early preterm birth in asymptomatic high-risk women. BJOG. 2013;120(8):1003-11.
[11] Darne J, McGarrigle HH, Lachelin GC. Increased saliva oestriol to progesterone ratio before preterm delivery: a possible predictor for preterm labor? Br Med J (Clin Res Ed). 1987;294(6567):270-272.
[12] Gil AM, Duarte D. Biofluid metabolomics in preterm birth research. Reprod Sci. 2018;25(7):967-977.
[13] Selvaraju V, Karthick PA, Swaminathan R. Analysis of frequency bands of uterine electromyography signals for the detection of preterm birth. Stud Health Technol Inform. 2021;281:283-287.
[14] Malaina I, Martinez L, Matorras R, Bringas C, Aranburu L, Fernández-Llebrez L, et al. Estimation of preterm labor immediacy by nonlinear methods. PLoS One. 2017;12(6):e0178257.
[15] Darne J, McGarrigle HH, Lachelin GC. Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: spontaneous labour at term is preceded by a rise in the saliva oestriol:progesterone ratio. Br J Obstet Gynaecol. 1987;94(3):227-235.
[16] Ilicic M, Zakar T, Paul JW. Epigenetic regulation of progesterone receptors and the onset of labour. Reprod Fertil Dev. 2019;31(6):1035-1048.
[17] Klebanoff MA, Meis PJ, Dombrowski MP, Zhao Y, Moawad AH, Northen A, et al. Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol. 2008;199(5):506.e1-7.
[18] Bell R. Antenatal oestradiol and progesterone concentrations in patients subsequently having preterm labour. Br J Obstet Gynaecol. 1983;90(10):888-891.
[19] Priya B, Mustafa MD, Guleria K, Vaid NB, Banerjee BD, Ahmed RS. Salivary progesterone as a biochemical marker to predict early preterm birth in asymptomatic high-risk women. BJOG. 2013;120(8):1003-1011.
[20] Abuelghar WM, Ellaithy MI, Swidan KH, Allam IS, Haggag HM. Prediction of spontaneous preterm birth: salivary progesterone assay and transvaginal cervical length assessment after 24 weeks of gestation, another critical window of opportunity. J Matern Fetal Neonatal Med. 2019;32(22):3847-3858.
[21] Rennert KN, Breuking SH, Schuit E, Bekker MN, Woiski M, de Boer MA, et al. Change in cervical length after arrested preterm labor and risk of preterm birth. Ultrasound Obstet Gynecol. 2021;58(5):750-756.
[22] Kuusela P, Wennerholm UB, Fadl H, Wesström J, Lindgren P, Hagberg H, et al. Second trimester cervical length measurements with transvaginal ultrasound: A prospective observational agreement and reliability study. Acta Obstet Gynecol Scand. 2020;99(11):1476-1485.
[23] Woźniak M, Paluszkiewicz C, Kwiatek WM. Saliva as a non-invasive material for early diagnosis. Acta Biochim Pol. 2019;66(4):383-388.
License
Copyright (c) 2024 Infomedic Intl.Derechos autoriales y de reproducibilidad. La Revista RevCog es un ente académico, sin fines de lucro, que forma parte de la Sociedad Centroamericana de Ginecología y Obstetricia. Sus publicaciones son de tipo ACCESO GRATUITO y PERMANENTE de su contenido para uso individual y académico, sin restricción. Los derechos autoriales de cada artículo son retenidos por sus autores. Al Publicar en la Revista, el autor otorga Licencia permanente, exclusiva, e irrevocable a la Sociedad para la edición del manuscrito, y otorga a la empresa editorial, Infomedic International Licencia de uso de distribución, indexación y comercial exclusiva, permanente e irrevocable de su contenido y para la generación de productos y servicios derivados del mismo.
